©2019 by Jon Holden DeHaan Foundation.

SCCT 2018

Dr. Kelly Han

Posted July 5, 2018 - Dr. Kelly Han, Director of Advanced Congenital Cardiac Imaging at the Minneapolis Heart Institute and Children’s Heart Clinic at Minnesota Children’s Hospital will be presented with the first of The Jon DeHaan Foundation Award for Innovation in Cardiology.


Dr. Han is being recognized by the Foundation for her outstanding contributions to improving both safety and quality of imaging Congenital Heart Disease in adults, children, and infants. She has also made significant contributions to treating and caring for adult women with congenital heart disease who either want to become pregnant or have become pregnant and have special considerations due to their impaired cardiac status.


Dr. Han is a recognized leader in the field, has published extensively on the use of CT in CHD patients of all ages, and lectures nationally and internationally. Her training includes pediatric residency at Johns Hopkins Hospital, pediatric cardiology fellowship at the university of California, San Francisco and an advanced imaging fellowship at Boston Children’s hospital/Harvard Medical School. She is boarded in pediatrics, pediatric cardiology and adult congenital heart disease and has level 3 certification in both cardiovascular MRI and CT. Her current clinical work includes imaging and clinical care of patients with CHD from fetal life through adulthood.


With The Jon DeHaan Foundation’s Award for Innovation in Cardiology, Dr. Han will fund: 1. Creation and expansion of a specialty inclusive multi-institutional congenital cardiovascular CT registry. The goal of the registry is evaluate current use and variability of diagnostic risk for CT in CHd patients of all ages from neonates to older adults. The second phase of the registry will evaluate diagnosis specific clinical utilization and effect on diagnostic algorithms and clinical care.

2. Creation of a multi/institution consortium to evaluate cumulative diagnostic risk of different care pathways for patients with single ventricle heart disease. This group of patients has among the highest diagnostic risk of CHd patients. The primary aim of the study is to evaluate clinical outcomes at the time of third stage palliation (Fontan procedure) for patients undergoing non-invasive evaluation compared to the standard of invasive catheterization for interstate diagnostic evaluation. 3. Creation of a sustainable, high quality and specialty inclusive educational platform for CT in CHD. The primary aim of this initiative is to build a program that builds on the knowledge and experience all cardiac imagers, whether from a pediatric or adult, cardiology or radiology background.


Dr. Robert Schwartz of the Minneapolis Heart Institute and Foundation will present the Minneapolis Heart Institute Foundation $200, 000 on behalf of the Jon DeHaan Foundation. The award will be presented to Dr. Han at the annual Society for Cardiovascular Computed Tomography (SCCT) conference in Dallas on July 13, 2018.